Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
5.99
+0.12 (2.04%)
Mar 28, 2025, 4:08 PM HKT
HKG:1066 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Revenue | 13,087 | 13,229 | 13,747 | 13,209 | 11,622 | Upgrade
|
Revenue Growth (YoY) | -1.08% | -3.77% | 4.08% | 13.65% | 11.93% | Upgrade
|
Cost of Revenue | 6,551 | 6,619 | 6,454 | 5,873 | 5,144 | Upgrade
|
Gross Profit | 6,536 | 6,611 | 7,293 | 7,336 | 6,478 | Upgrade
|
Selling, General & Admin | 3,629 | 3,832 | 3,659 | 3,814 | 3,618 | Upgrade
|
Research & Development | 625.23 | 592.85 | 556.44 | 503.08 | 424.42 | Upgrade
|
Operating Expenses | 4,263 | 4,430 | 4,251 | 4,333 | 4,075 | Upgrade
|
Operating Income | 2,273 | 2,181 | 3,043 | 3,003 | 2,403 | Upgrade
|
Interest Expense | -249.57 | -272.97 | -191.4 | -140.44 | -178.94 | Upgrade
|
Interest & Investment Income | 232.6 | 238.57 | 187.31 | 156.23 | 135.61 | Upgrade
|
Earnings From Equity Investments | 74.77 | 76.86 | 75.11 | 69.46 | 9.17 | Upgrade
|
Currency Exchange Gain (Loss) | 56.44 | -16.6 | 138.33 | -68.1 | -56.3 | Upgrade
|
Other Non Operating Income (Expenses) | 159.21 | 138.92 | 158.23 | 90.63 | 208.34 | Upgrade
|
EBT Excluding Unusual Items | 2,546 | 2,346 | 3,410 | 3,111 | 2,521 | Upgrade
|
Gain (Loss) on Sale of Investments | 0.26 | 5.97 | 137.16 | - | 33.13 | Upgrade
|
Gain (Loss) on Sale of Assets | 2.91 | -1.55 | 108.75 | -2.93 | 1.68 | Upgrade
|
Asset Writedown | -0.17 | -9.7 | -10.81 | - | -6.87 | Upgrade
|
Legal Settlements | 4.47 | 28.55 | -259.61 | -229.85 | - | Upgrade
|
Other Unusual Items | - | - | - | - | 16.86 | Upgrade
|
Pretax Income | 2,554 | 2,369 | 3,386 | 2,878 | 2,565 | Upgrade
|
Income Tax Expense | 391.03 | 307.59 | 435.59 | 420.07 | 358.42 | Upgrade
|
Earnings From Continuing Operations | 2,163 | 2,062 | 2,950 | 2,458 | 2,207 | Upgrade
|
Net Income to Company | 2,163 | 2,062 | 2,950 | 2,458 | 2,207 | Upgrade
|
Minority Interest in Earnings | -96.05 | -59.7 | -186.06 | -181.85 | -120.25 | Upgrade
|
Net Income | 2,067 | 2,002 | 2,764 | 2,276 | 2,087 | Upgrade
|
Net Income to Common | 2,067 | 2,002 | 2,764 | 2,276 | 2,087 | Upgrade
|
Net Income Growth | 3.23% | -27.57% | 21.45% | 9.06% | 12.80% | Upgrade
|
Shares Outstanding (Basic) | 4,539 | 4,508 | 4,506 | 4,501 | 4,489 | Upgrade
|
Shares Outstanding (Diluted) | 4,549 | 4,519 | 4,527 | 4,516 | 4,493 | Upgrade
|
Shares Change (YoY) | 0.66% | -0.17% | 0.23% | 0.52% | 0.23% | Upgrade
|
EPS (Basic) | 0.46 | 0.44 | 0.61 | 0.51 | 0.46 | Upgrade
|
EPS (Diluted) | 0.45 | 0.44 | 0.61 | 0.50 | 0.46 | Upgrade
|
EPS Growth | 2.27% | -27.92% | 21.18% | 9.51% | 12.20% | Upgrade
|
Free Cash Flow | - | 2,151 | 1,225 | 1,967 | 1,881 | Upgrade
|
Free Cash Flow Per Share | - | 0.48 | 0.27 | 0.43 | 0.42 | Upgrade
|
Dividend Per Share | 0.215 | 0.168 | 0.165 | 0.142 | 0.130 | Upgrade
|
Dividend Growth | 28.44% | 1.64% | 16.20% | 9.23% | 8.33% | Upgrade
|
Gross Margin | 49.94% | 49.97% | 53.05% | 55.54% | 55.74% | Upgrade
|
Operating Margin | 17.37% | 16.49% | 22.13% | 22.73% | 20.67% | Upgrade
|
Profit Margin | 15.79% | 15.13% | 20.11% | 17.23% | 17.95% | Upgrade
|
Free Cash Flow Margin | - | 16.26% | 8.91% | 14.89% | 16.18% | Upgrade
|
EBITDA | 3,142 | 3,051 | 3,809 | 3,708 | 3,091 | Upgrade
|
EBITDA Margin | 24.01% | 23.06% | 27.70% | 28.07% | 26.60% | Upgrade
|
D&A For EBITDA | 869.38 | 869.38 | 765.98 | 705.58 | 688.27 | Upgrade
|
EBIT | 2,273 | 2,181 | 3,043 | 3,003 | 2,403 | Upgrade
|
EBIT Margin | 17.37% | 16.49% | 22.13% | 22.73% | 20.67% | Upgrade
|
Effective Tax Rate | 15.31% | 12.98% | 12.86% | 14.60% | 13.97% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.